Skip to content
2000
Volume 8, Issue 3
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Dronedarone was introduced in 2009 as a new antiarrhythmic agent and since then has been increasingly prescribed in atrial fibrillation or flutter. To date, two cases of severe toxic hepatitis have been reported in patients treated with dronedarone, both requiring emergency liver transplantation, and the FDA as well as the EMA have issued warnings about possible severe hepatotoxicity of dronedarone. Here we report an additional case of toxic hepatitis associated with dronedarone presenting with acute liver failure, followed by spontaneous recovery, in a 69-year old woman.

Loading

Article metrics loading...

/content/journals/cds/10.2174/15748863113089990031
2013-07-01
2025-07-09
Loading full text...

Full text loading...

/content/journals/cds/10.2174/15748863113089990031
Loading

  • Article Type:
    Research Article
Keyword(s): Dronedarone; drug-induced liver injury
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test